Skip to main content

Web Exclusives

Prostate Cancer, FDA Updates

Lynparza First Targeted Therapy Approved for Metastatic Prostate Cancer with HRR Mutation

Lung Cancer, FDA Updates

Tecentriq Approved as First-Line Therapy for Metastatic NSCLC with High PD-L1 Expression

COVID-19

Washington and COVID-19: The Government Response

COVID-19

Oncology Nurse Navigators Take on COVID-19 Challenge

COVID-19

The Impact of COVID-19 on Cancer Research and Investigational Studies

COVID-19

COVID-19: Impact on Telehealth

COVID-19

Employers and the Impact of COVID-19

Lung Cancer, FDA Updates

Opdivo-Yervoy First Immunotherapy Combo Approved for First-Line Therapy of Patients with Metastatic NSCLC

FDA Updates

Tabrecta First FDA-Approved Targeted Therapy for Metastatic NSCLC and MET Exon 14 Skipping

FDA Updates

Retevmo First Therapy Approved for 3 Types of Cancers with RET Mutations

Page 15 of 43
Results 141 - 150 of 430